ISSN: 2155-9554
+44 1478 350008
Reza F. Ghohestani
Texas Institute of Dermatology, USA
Keynote: J Clin Exp Dermatol Res
Molecular diagnostic testing is beginning to play a key role in facilitating the diagnosis, staging, and prognostication of a variety of other skin diseases. Personalized Dermatology would allow physicians to investigate a patient���¢��������s genetic information to develop a treatment plan uniquely suited to that particular patient. In this approach, no trial-and-error approach is necessary. In this talk, recent advances in personalized approach toward improving our treatment plan for challenging skin diseases will be discussed.
Reza Fredrick Ghohestani is Director of Texas Institute of Dermatology. He was Chief of Dermatology of University of Texas and Editor of European Journal of Dermatology. He received numerous international awards for his dermatology research.